A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lubiprostone for the Treatment of Chronic Idiopathic Constipation
Phase of Trial: Phase III
Latest Information Update: 19 Jun 2017
At a glance
- Drugs Lubiprostone (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Takeda
- 13 Jun 2017 Status changed from active, no longer recruiting to completed.
- 10 May 2017 Status changed from recruiting to active, no longer recruiting.
- 09 Jun 2016 Status changed from not yet recruiting to recruiting.